SOSV GP & HAX Managing Director Duncan Turner was named one of Fortune’s top 13 seed stage climate tech VCs to watch. Fortune noted how Turner “uses his design engineering background to help climate tech founders get their product to market—a core skill that can be especially challenging for founders when the market constitutes a […]

SOSV Founder & Managing General Partner Sean O’Sullivan recently sat down with Bloomberg to discuss his storied career in climate tech and share his vision for the future of the all-important category. O’Sullivan has “quietly been one of the leading investors in the technology that could redefine what we eat, what we wear, how we […]

At SOSV, one of our core missions is the advancement of human health, and over the past decade or more we’ve pursued that mission in fields as varied as cancer therapeutics, CRISPR diagnostic platforms, assistive robotics, and remote healthcare, to name a few. More than 200 companies in our 1000+ company portfolio focus on health, and recently we sat down to rank our top 100, based on current as well as expected performance. The result is our first annual SOSV Human Health 100, which is presented below.

Solvay Ventures, the venture capital fund of Solvay, announced that the fund has joined the Genesis Consortium to support startups in SOSV’s IndieBio startup development program, which holds a portfolio of early-stage, venture-backed companies innovating in planetary and human health. The Genesis Consortium, founded by SOSV and Mayfield, is a global alliance of venture capital firms and corporations dedicated to supporting […]

When Covid hit, it wasn’t clear what the effect would be on our organization and portfolio.  Should we keep investing? Can we operate effectively? How will our startups respond? How can we help them? SOSV’s mission is to address the challenges of human and planetary health. And human health was calling. “In times of need, […]

At SOSV, one of our core missions is the advancement of human health, and over the past decade or more we’ve pursued that mission in fields as varied as cancer therapeutics, CRISPR diagnostic platforms, assistive robotics, and remote healthcare, to name a few. More than 200 companies in our 1000+ company portfolio focus on health, and recently we sat down to rank our top 100, based on current as well as expected performance. The result is our first annual SOSV Human Health 100, which is presented below.

Partnership to promote next-generation startups driving advancements at the intersection of sustainability, nutrition, health and wellness. ADM Ventures, the corporate venture capital arm of ADM, today announced its collaboration with the Genesis Consortium. Genesis, founded by Silicon Valley-based investors SOSV and Mayfield Fund, is a global alliance of venture capital firms and corporations dedicated to […]

For more than a decade, SOSV’s founder and managing partner, Sean O’Sullivan, has been putting venture investing to work in support of climate tech startups.

Firms to invest $400 million in seed and early-stage funding over the next four years to propel the next tech revolution. In a move reflecting the shifting landscape of technology investing, SOSV and Mayfield are jointly doubling down on a commitment to early-stage life science startups. The effort, which they dub the “Genesis Consortium”, will provide a strong foundation […]